Trial shows the efficacy of anti-TNF drug for patients with early-stage Dupuytren’s disease

By | May 1, 2022
Researchers at the Kennedy Institute, University of Oxford, led by Professor Jagdeep Nanchahal have demonstrated the efficacy of the anti-TNF drug adalimumab for patients with early-stage Dupuytren’s disease.